22 employees
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
2009
$7M
from 1 investors over 1 rounds
Brickell Biotech raised $7M on February 26, 2013
Investors: Palisade Capital Management